on May 20, 2004
Published online before print May 20, 2004, doi: 10.1161/01.STR.0000131808.69640.b7
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 4, 2004
From Department of Neuroscience (P.A.L., J.A.Z.), University of California San Diego; Veterans Administration San Diego Healthcare System (P.A.L., J.W., J.A.Z.), San Diego, Calif; Veterans Medical Research Foundation (P.A.L., J.W., J.A.Z.), San Diego, Calif. * To whom correspondence should be addressed. E-mail: plapchak{at}ucsd.edu.
Background and Purpose--Because photon energy delivered using a low-energy infrared laser may be useful to treat stroke, we determined whether transcranial laser therapy would improve behavioral deficits in a rabbit small clot embolic stroke model (RSCEM). Methods--In this study, the behavioral and physiological effects of laser treatment were measured. The RSCEM was used to assess whether low-energy laser treatment (7.5 or 25 mW/cm2) altered clinical rating scores (behavior) when given to rabbits beginning 1 to 24 hours postembolization. Behavioral analysis was conducted from 24 hours to 21 days after embolization, allowing for the determination of the effective stroke dose (P50) or clot amount (mg) that produces neurological deficits in 50% of the rabbits. Using the RSCEM, a treatment is considered beneficial if it significantly increases the P50 compared with the control group. Results--In the present study, the P50 value for controls were 0.97±0.19 mg to 1.10±0.17 mg; this was increased by 100% to 195% (P50=2.02±0.46 to 2.98±0.65 mg) if laser treatment was initiated up to 6 hours, but not 24 hours, postembolization (P50=1.23±0.15 mg). Laser treatment also produced a durable effect that was measurable 21 days after embolization. Laser treatment (25 mW/cm2) did not affect the physiological variables that were measured. Conclusions--This study shows that laser treatment improved behavioral performance if initiated within 6 hours of an embolic stroke and the effect of laser treatment is durable. Therefore, transcranial laser treatment may be useful to treat human stroke patients and should be further developed.
Revised on April 14, 2004
Accepted on April 22, 2004
Transcranial Infrared Laser Therapy Improves Clinical Rating Scores After Embolic Strokes in Rabbits
Paul A. Lapchak PhD*;
Key words: laser • neuroprotection • embolism • stroke, acute • stroke, ischemic • clinical trials
This article has been cited by other articles:
 |
|
 |
|
  J. A. Zivin, G. W. Albers, N. Bornstein, T. Chippendale, B. Dahlof, T. Devlin, M. Fisher, W. Hacke, W. Holt, S. Ilic, et al. Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke Stroke, April 1, 2009; 40(4): 1359 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lapchak, M.-K. Han, K. F. Salgado, J. Streeter, and J. A. Zivin Safety Profile of Transcranial Near-Infrared Laser Therapy Administered in Combination With Thrombolytic Therapy to Embolized Rabbits Stroke, November 1, 2008; 39(11): 3073 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singhal and E. H. Lo Advances in Emerging Nondrug Therapies for Acute Stroke 2007 Stroke, February 1, 2008; 39(2): 289 - 291. [Full Text] [PDF]
|
|
|
|
|
|
Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, et al. Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1) Stroke, June 1, 2007; 38(6): 1843 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oron, U. Oron, J. Chen, A. Eilam, C. Zhang, M. Sadeh, Y. Lampl, J. Streeter, L. DeTaboada, and M. Chopp Low-Level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-Term Neurological Deficits Stroke, October 1, 2006; 37(10): 2620 - 2624. [Abstract] [Full Text] [PDF]
|
|